During oncology treatments, frequent visits to the
physician/practioner are common place to understand the progress of
treatment.
The relevant blood tests associated with therapy involve
infection level monitoring and internal bleeding evaluation.
We strive to improve the health & survival rates in cancer
care!
Our validation partners
Introducing
HomeCyteTM
A portable, point-of-care blood analyzer.
How to perform the test - easy and simple
Log in
Choose ,,Patient Test''
Scan the patient ID, scan the PAQ barcode
Collect the blood and fill one drop into the PAQ
Insert PAQ and wait approx. 7 minutes
Stream the results
We provide value for both - patients & healthcare providers.
Reducing infection risks
Severely reducing risks of at-hospital infection for patients.
Comfort
Patients take comfort of their homes or at point-of-care.
Cost - saving
Decreasing the patient need to visit hospital to get diagnosed reduces costs.
Instant medical help
1 hour delay in antibiotic dosage increases mortality by 8%.
Versatile
Many parameters means a single device for greater diagnostics value.
Time - saving
Empowering chronic care management processes saves time for clinicians.
The solution consists of a few hardware components.
As well as algorithmics, which are machine learning classifiers trained to pick electrical signature to quantify size, shape and granularity of each cell and for optical signatures of protein measurements.
-
Reader
A portable device to insert cartridges and stream the results to cloud.
-
Cartridges
A consumable needed to perform the tests, loaded with reagents with integrated cell flow. Cartridge is repurposable for various tests.
-
The sensor
A Microfluidics impedance cytometer for measuring cellular 3- dimensional information of up to 1 micron.
HomeCyte
HomeCyte is a remote patient monitoring tool, to help reduce the stress to manage cancer care for all stake holders’ patients, physicians and payers.
It comprises of a portable instrument and disposable set of cartridges or measurement of:
- CBC (complete blood cell count) in under 7 minutes
- Protein markers (C-reactive protein, Procalcitonin and IL-6 in) under 20 minutes each.
Publications
A cartridge based Point-of-Care device for complete blood count.
Scientific reports
Fabrication of Microfluidic Impedance Cytometer for Leukocytes Analysis
IEEE Xplore
A New Approach for Accurate Determination of Particle Sizes in Microfluidic Impedance Cytometry
SSRN
Automatic detection of dysplastic cells using deep learning
Wiley.com
The microxlabs team
Our scientific advisors & clinical partners
Prof. Hywel Morgan
Electronics and Nanotech
University of Southampton, UK Head of Nanofabrication
Prof. V Kumaran
Fluid Dynamics
Institute Chair Professor at Department of Chemical Engineering, Indian Institute of Science, Bangalore
Sibylle Hauser
Business Dev, M&A
Ex Roche M&A ; Current - Executive Director, Innovation Services California Life Sciences (CLS)
Prof. Velavan
Infectious diseases, antimicrobial resistance, coronavirus, malaria, University of Tubingen, Germany.
Dr Ryan Shea Tan
National Cancer Center, Singapore Chairman, IT enabled workgroup.
Jim Mulry
Head of Diagnostics Merck Global Health Institute, 35 years of experience in hematology, sales and business development, Global Health Institute
Prof. Nathan Swami
Professor of Electrical & Computer Engineering at the, VA University of Virginia, USA
Prof. Ewa Balcerczak
Head of laboratory
Medical University of Łódź, Horiba–Lodz, Poland
Dr. De Botton
Leukemia oncologist (20 years) Gustave Rossy, Paris
SCIENTIFIC ADVISORS
Prof. Hywel Morgan
Electronics and Nanotech
University of Southampton, UK Head of Nanofabrication
Prof. V Kumaran
Fluid Dynamics
Institute Chair Professor at Department of Chemical Engineering, Indian Institute of Science, Bangalore
Sibylle Hauser
Business Dev, M&A
Ex Roche Executive Director, Innovation Services California Life Sciences (CLS)
CLINICAL PARTNERS
Prof. Velavan
Infectious diseases, antimicrobial resistance, coronavirus, malaria, University of Tubingen, Germany.
Dr Ryan Shea Tan
National Cancer Center, Singapore Chairman, IT enabled workgroup.
Jim Mulry
Head of Diagnostics Merck Global Health Institute, 35 years of experience in hematology, sales and business development, Global Health Institute
Prof. Nathan Swami
Professor of Electrical & Computer Engineering at the, VA University of Virginia, USA
Prof. Ewa Balcerczak
Head of laboratory
Medical University of Łódź, Horiba–Lodz, Poland
Dr. De Botton
Leukemia oncologist (20 years) Gustave Rossy, Paris
